- Home
- CLDI vs TRT Comparison
CLDI vs TRT Comparison
Compare CLDI & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- TRT
- Stock Information
- Founded
- CLDI 2014
- TRT 1958
- Country
- CLDI United States
- TRT United States
- Employees
- CLDI N/A
- TRT N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- TRT Industrial Machinery/Components
- Sector
- CLDI Health Care
- TRT Technology
- Exchange
- CLDI Nasdaq
- TRT Nasdaq
- Market Cap
- CLDI 20.2M
- TRT 22.7M
- IPO Year
- CLDI N/A
- TRT N/A
- Fundamental
- Price
- CLDI $1.62
- TRT $5.25
- Analyst Decision
- CLDI
- TRT
- Analyst Count
- CLDI 0
- TRT 0
- Target Price
- CLDI N/A
- TRT N/A
- AVG Volume (30 Days)
- CLDI 485.8K
- TRT 2.6K
- Earning Date
- CLDI 11-11-2025
- TRT 11-11-2025
- Dividend Yield
- CLDI N/A
- TRT N/A
- EPS Growth
- CLDI N/A
- TRT N/A
- EPS
- CLDI N/A
- TRT 0.00
- Revenue
- CLDI N/A
- TRT $35,548,000.00
- Revenue This Year
- CLDI N/A
- TRT N/A
- Revenue Next Year
- CLDI N/A
- TRT N/A
- P/E Ratio
- CLDI N/A
- TRT $1,191.70
- Revenue Growth
- CLDI N/A
- TRT N/A
- 52 Week Low
- CLDI $1.51
- TRT $4.62
- 52 Week High
- CLDI $46.68
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- CLDI 30.80
- TRT 43.61
- Support Level
- CLDI $1.51
- TRT $5.12
- Resistance Level
- CLDI $1.68
- TRT $5.50
- Average True Range (ATR)
- CLDI 0.12
- TRT 0.09
- MACD
- CLDI 0.13
- TRT -0.01
- Stochastic Oscillator
- CLDI 28.38
- TRT 34.21
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.